학술논문

Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial

Document Type

Article

Author

Weickert, T.W.; Jacomb, I.; Lenroot, R.; Weinberg, D.; Brooks, W.S.; Pellen, D.; Kindler, J.; Stanton, C.; O'Donnell, M.; Shannon Weickert, C.; Lappin, J.; Mohan, A.; Wakefield, D.; Brown, D.; Lloyd, A.R.; Liu, D.; Galletly, C.

Source

In: Brain, Behavior, and Immunity. (Brain, Behavior, and Immunity, January 2024, 115:191-200)

Subject

Language

English

ISSN

10902139
08891591

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송